Medical Laboratory Technology and Diagnostics Risk Assessment: Specimen, Analytical and Reporting Controls

This assessment shows how a diagnostic laboratory can find, rate and control the risks that matter most to patients, staff and service continuity. Eight risks were selected because they are plausible in everyday specimen handling, analysis, reporting and staffing. Specimen identification errors and critical result delays are the most serious, since they can reach a patient directly. Analytical quality failure and biological exposure also score high before controls. Each risk is scored before controls and again after existing and added controls. Most risks fall to Medium or Low once the additional controls are in place, while specimen identification and critical result notification remain at High because the impact stays serious. The first actions are two identifier checks with rejection logging, a rule blocking release when quality control fails, a measure of notification times and a tested downtime procedure. The laboratory is a teaching example, so every score illustrates method, not a real organization.

Scope

This assessment covers the work of a clinical diagnostic laboratory, from specimen receipt and preparation through analysis, result validation, reporting and disposal of waste. It looks at risks to patients, staff, equipment, information and continuity of service. It does not give clinical advice, choose treatment or replace laboratory accreditation. Assumptions: the country, care setting, accreditation regime and laboratory information system are not specified, so general practice is described and specialist review is needed for any real site.

Context

The laboratory receives samples from wards, clinics and outside referrers. It runs chemistry, hematology, microbiology and molecular tests on automated analysers, with a laboratory information system that holds orders, results and patient identifiers. Staff include biomedical scientists, technicians, a quality lead, an information systems manager and a duty manager on each shift. Each risk is scored before controls to show its natural level, then again after the existing controls and the additional controls proposed. The scores are for learning and do not describe any real laboratory.

Objectives, assets and stakeholders

The objective is to deliver accurate and timely results, protect patients and staff from harm, keep records private, and maintain continuity of testing. The assets in scope are specimens, analysers, reagents, the laboratory information system, patient records, stored samples and the reputation of the service. Stakeholders include patients, ward and primary care clinicians, laboratory staff, the duty manager, the quality team, information governance staff, suppliers and the regulators or accrediting bodies that apply to the site. Clear roles matter: every risk has one owner role, and the laboratory quality lead keeps the register current and reports to the governance group each quarter.

Each risk is rated on two five-point scales. Likelihood runs from Rare to Almost certain, and impact runs from Insignificant to Catastrophic. Multiplying the two gives a score from 1 to 25, which falls into one of four bands: Low from 1 to 4, Medium from 5 to 9, High from 10 to 16 and Critical from 17 to 25. The score is a guide for ordering work, not a measurement. Inherent risk is the score before any controls. Residual risk is the score after the existing and additional controls. Impact for patients is judged on the possible harm, the time to detect and correct the error, and the number of people affected, and a clinical risk is never rated down only because it has not yet happened. Anything Critical or High needs senior attention and a dated plan, anything Medium needs routine controls with a named owner, and anything Low is accepted and watched. Staff who do the work should challenge the ratings at each review, and any hazard is rescored whenever its early warning indicator reaches the threshold or an event is investigated.

Contingency arrangements

If a serious event occurs, such as a wrong patient result, an unreported critical value, a major analyser failure or a confirmed privacy breach, the duty manager stops affected testing and informs the responsible clinician at once. The information systems manager moves work to downtime forms and restores data from the latest tested backup. The quality lead records the event, starts a root cause review and informs the governance group. Patients are told what they need to know early and plainly through the proper clinical route.

Conclusion

Safe laboratory work depends on steady habits: two identifier checks, quality control that blocks release, timed notification of critical results, competence checks on every shift and tested downtime plans. The highest scores sit with specimen identity and critical result delay, and each has actions that bring the residual score down. Treat the register as a living record, review it on the stated cycle, and seek qualified clinical, laboratory and legal advice for any real decision.